Class IIOngoingD-0039-2025
Drug recall · November 13, 2024
Regadenoson Injection recall
Why: Labeling: Missing Label
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Regadenoson Injection, 0.4 mg/5 mL (0.08 mg/mL), 5mL Single-Dose Pre-filled Syringe, Rx only, Manufactured by: Baxter Pharmaceutical Solutions, LLC, Bloomington, IN 47403; Manufactured for: Baxter Healthcare Corporation, Deerfield, IL 60015. NDC: 36000-364-01
- Lots / codes
Lot #: 945169, Exp. Date 9/25/2025; 945170, Exp. Date 10/24/2025
- Quantity
- 60,594 units
- Company
- Baxter Healthcare Corporation, Deerfield, IL
- Distribution
- Nationwide within the USA
- Initiated
- October 30, 2024 · Voluntary: Firm initiated
- Classified
- November 6, 2024
- Reported
- November 13, 2024
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.